Posts Tagged: AbbVie
China extends drug patent exclusivity to 25 years
Among members of the news media, patents have been a popular whipping boy when contemplating why Americans pay higher drug prices relative to the rest of the …
The Abuse of Orange Book Listings by Branded Pharmaceutical Companies
AbbVie’s maneuver worked like clockwork to induce regulatory gridlock, which prevented generic competition and kept the company’s profits high at public expense, for years. Fortunately, …
Drug-Patent Abuse and the High Cost of Healthcare: Case of the Double-Half Dose-Time Injection
Ever since the Supreme Court decided KSR v. Teleflex, it has been appropriate to reject a patent claim because it was obvious to try. If twice the …
Litigants May Not Use a DJ to Obtain Piecemeal Adjudication
The Federal circuit heard the case on AbbVie Inc. v. MedImmune Ltd. AbbVie and MedImmune entered a development and licensing agreement in 1995. The agreement stemmed from a …
When Post-Filing Evidence to Determine Written Description Support Is Admissible: Amgen v. Sanofi
May a court rely on post-priority-date evidence offered to show that a patent lacks written description support even though written description is judged based on the state …
Patent settlement between AbbVie and Amgen delays Humira generic until 2023
On Thursday, September 28th, a judge in the District of Delaware entered an order stipulating dismissal in a patent infringement case brought by North Chicago-based pharmaceutical firm …
Genetic and Stem Cell Therapies to Treat Cancers
There are certainly some signs for hope. One of them came recently from Princeton University, where graduate students worked on a project which identified a treatment for …
FTC Sues to Stop Unlawful Blocking of Generic Androgel
The FTC is seeking a court judgment declaring that the defendants’ conduct violates the FTC Act, ordering the companies to disgorge their ill-gotten gains, and permanently barring …
Biotech and Pharma Update: January 2014
Kava Plant May Prevent Cigarette Smoke-induced Lung Cancer *** Conditional Approval for Treatment of T-cell Lymphoma in Dogs *** All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C Genotype 1 *** …
